XML 27 R15.htm IDEA: XBRL DOCUMENT v3.24.2
Note 7 - Marketable Securities
6 Months Ended
Jun. 30, 2024
Notes to Financial Statements  
Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]

7. MARKETABLE SECURITIES

 

The fair value of marketable securities, which were all classified as available for sale and which the Company does not intend to sell nor will the Company be required to sell prior to recovery of their amortized cost basis, included the following (in thousands):

 
  

June 30, 2024

 
  

Adjusted Cost

  

Unrealized Gains

  

Unrealized Losses

  

Fair Value

 

Level 2:

                

U.S. treasury securities

 $36,867  $4  $(2) $36,869 

Total

 $36,867  $4  $(2) $36,869 
 
  

December 31, 2023

 
  

Adjusted Cost

  

Unrealized Gains

  

Unrealized Losses

  

Fair Value

 

Level 2:

                

U.S. treasury securities

 $30,791  $10  $(1) $30,800 

Total

 $30,791  $10  $(1) $30,800 

 

The carrying amounts reported in the Condensed Consolidated Balance Sheets approximate fair value based on quoted market prices or alternative pricing sources and models utilizing market observable inputs. As of June 30, 2024, the Company did not recognize any allowance for credit impairments on its available for sale securities. All investments in marketable securities are classified as current assets on the Condensed Consolidated Balance Sheets because the underlying securities mature within one year from the balance sheet date.